LiveLoadingtotal visitors

Open source
Future research

The artificial pancreas as a feedback system

Understand how a CGM, control algorithm, insulin pump, and human physiology form a loop—and what the loop does not solve.

2 min readMedium read2 sourcesChecked 30 Sept 2026Strong Evidence

By The Diabetes Guide editorial project · Updated 30 Sept 2026

On this page
In simple words

An artificial pancreas links a sensor, a computer program and an insulin pump into a loop that adjusts insulin automatically.

  1. Step 1: The loop

    Sensor reads, algorithm decides, pump delivers, body responds.

    For example: A thermostat that reads the room and turns the heater up or down.

  2. Step 2: Delays

    Sensors lag and insulin takes time to work, so the program must predict ahead.

    For example: Steering a big ship, you must turn early.

  3. Step 3: Still needed

    Supplies, training and a backup plan.

    For example: Even an autopilot needs a pilot ready to help.

Remember: It manages sugar; it does not repair the cells or stop autoimmunity.

The full story

Want more? Below is the detailed version with the real science words. It is fine to skip it.

The system architecture

CGM → algorithm → insulin pump → body → CGM. The sensor estimates interstitial glucose. The algorithm predicts near-term behavior within safety constraints. The pump delivers insulin, which takes time to absorb and act. The resulting glucose feeds back into the next decision. 1

Step by stepA simple model

The artificial pancreas feedback loop

↺ This is a loop: the end feeds back to the start.

CGM sensor. Estimates glucose in interstitial fluid; sensing and physiology introduce delays.

Read every step in a list
  1. CGM sensor. Estimates glucose in interstitial fluid; sensing and physiology introduce delays.
  2. Algorithm. Predicts trends within device-specific safety constraints.
  3. Insulin pump. Adjusts delivery; insulin absorption is delayed and cannot be instantly reversed.
  4. Body response. Meals, activity, stress and infusion-site reliability affect the response.
A control system that manages glucose. It does not repair beta cells or eliminate autoimmunity. Source: American Diabetes Association

Delays and disturbances

Meals, exercise, stress, illness and infusion-site changes disturb the system. Once insulin is delivered, the algorithm cannot recall it. A sensor has noise and lag. Many systems still require user input or meal announcements; “closed loop” does not necessarily mean fully autonomous daily life.

What it solves—and what remains

Automated delivery can improve glucose management and reduce burden for appropriate users. It does not restore beta cells or stop autoimmunity. Connectivity, supply access, training, hypoglycemia prevention and a backup plan remain essential. 2

Trace the evidence

Sources and further reading

1.Diabetes Technology: Standards of Care 2026 (opens in a new tab)

American Diabetes Association · 2026 · Guideline

Strong Evidence
Who was studied, limits and source check

Limitations: Access, training, device labeling, and safe-use capacity affect applicability.

Source checked 2026-09-30. See the original publication for full methods.

Source checking is an editorial literature check, not independent medical review. This page is for learning. It cannot diagnose you or make a treatment plan. Evidence labels describe the cited claims, not the whole topic.

What does “Strong Evidence” mean?

Many good studies agree, with a few limits. Like a big taste test where almost everyone picked the same flavor.

Keep reading

The body

The one-page mental model

Diabetes means there is too much sugar in the blood for too long, because the body does not have enough insulin or cannot use it well.

4 minEasy read

Type 1

Type 1 diabetes: the complete journey

Type 1 diabetes is usually an autoimmune condition. The body’s defence system harms the beta cells, so less and less insulin is made.

4 minEasy read